5 Best Cannabis Stocks To Buy Now

Page 5 of 5

1. Jazz Pharmaceuticals plc (NASDAQ:JAZZ)

Number of Hedge Fund Holders: 40

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) is a biopharmaceutical company committed to advancing research, development, and worldwide distribution of pharmaceutical products and immunotherapies to meet unaddressed medical needs. Leveraging its GW Cannabinoid Platform, Jazz Pharmaceuticals plc (NASDAQ:JAZZ) is a key player in the realm of cannabinoid science.

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) unveiled its financial performance for the third quarter of 2023 on November 8, demonstrating strong results with total revenues hitting $972 million. Notably, the company’s primary growth catalysts—Xywav, Epidiolex, and Rylaze—experienced a collective revenue surge, marking a noteworthy 24% increase year-over-year.

According to Insider Monkey’s third quarter database, 40 hedge funds were bullish on Jazz Pharmaceuticals plc (NASDAQ:JAZZ), down from 44 funds in the last quarter. Robert Pohly’s Samlyn Capital held the largest position in the company, with 1.35 million shares worth $175.88 million.

You can also take a look at 14 Best Cyclical Stocks To Invest In and 10 Best Regional Bank ETFs.

Page 5 of 5